Colorectal Cancer Drugs Global Market To Reach Value Of About $7 Billion In 2025
8 Nov, 2021
The colorectal cancer drugs market consists of sale of colorectal cancer drugs. Colorectal cancer (CRC) or bowel cancer, is the cancer affecting large intestine and the rectum. They are also named, colon tumor or rectal cancer depending upon where they begin.
Global Colorectal Cancer Drugs Market Size And Drivers:
The global colorectal cancer drugs market is expected to decline from $6.23 billion in 2020 to $6.09 billion in 2021 at a compound annual growth rate (CAGR) of -2.2%. The slow decline is mainly due to the outbreak of COVID-19 that has led to decrease in demand for immunocompromised treatments. The colorectal cancer drugs market is expected to reach $6.85 billion in 2025 at a CAGR of 3%. The increase in number of colorectal cases will add to the overall size of the global colorectal cancer drugs market.
Request For A Sample For The Global Colorectal Cancer Drugs Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2590&type=smp
Trends In The Global Colorectal Cancer Drugs Market
Increasing use of biologics and targeted therapies restrains the bladder cancer drugs market. Biologic therapy uses a body’s immune system to fight cancer rather than chemical drugs which reduces the body’s immune power. Targeted therapies block the growth and spreading of colorectal cancer even in stage IV where chemical drugs are ineffective. For example, some targeted therapies that have been approved to treat colorectal cancer include bevacizumab, cetuximab and panitumumab. The advantages of biologics drugs and targeted therapies over conventional chemical drugs might negatively influence the market.
Global Colorectal Cancer Drugs Market Segments:
The global colorectal cancer drug market is further segmented –
By Type: Vascular Endothelial Growth Factor (VEGF) Inhibitors, Epidermal Growth Factor Receptor (EGFR) Inhibitors, Programmed Cell Death Protein 1/PD1 Ligand 1 (PD1/PDL1) Inhibitors, BRAF or MEK Inhibitors, Tyrosine Kinase (TKI) Inhibitors, Immunomodulators
By Distribution Channels: Hospitals Pharmacies, Retail Pharmacies, Others
By Class: Immunotherapy, Chemotherapy, Others
By Geography: The global colorectal cancer market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.
Read More On The Report For The Global Colorectal Cancer Drugs Market At:
https://www.thebusinessresearchcompany.com/report/colorectal-cancer-drugs-global-market-reportColorectal Cancer Drugs Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides colorectal cancer drugs market overviews, analyzes and forecasts market size and growth for the global colorectal cancer drugs market, colorectal cancer drugs market share, colorectal cancer drugs market players, colorectal cancer drugs market segments and geographies, colorectal cancer drugs market’s leading competitors’ revenues, profiles and market shares. The colorectal cancer drugs market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.